REFERENCES
- Eddeland A, Ohlsson K. Scand J Clin Lab Invest 1978, 38, 261–267
- Haverback BJ, Dyce B, Bundy H, Edmondson HA. Am J Med 1962, 29, 424
- Eddeland A, Ohlsson K. Scand J Clin Lab Invest 1976, 36, 815–820
- Greene LJ, DiCarlos JJ, Sussman AJ, Bartelt DC. J Biol Chem 1968, 243, 1804
- Greene LJ, Rigbi M, Fachre DS. J Biol Chem 1966, 241, 5610–5618
- Marks WH, Ohlsson K. Biochim Biophys Acta 1982, 717, 91–97
- Eddeland A, Ohlsson K. Scand J Clin Lab Invest 1978, 38, 507–515
- Eddeland A. Hoppe-Seylers Z Physiol Chem 1979, 360, 145–149
- Ogawa M, Fujimoto K, Kitahara T, Iwaki K, Murata A, Kosaki G. World J Surg 1981, 5, 425
- Eddeland A, Ohlsson K. Hoppe-Seylers Z Physiol Chem 1978, 358, 671–675
- Kitahara T, Takatsuka Y, Fusimoto KI, Tanaka S, Ogawa M, Kosaki G. Clin Chim Acta 1980, 103, 135–143
- Balldin G. Personal communication, 1981
- Thorell JI, Johansson BG. Biochim Biophys Acta 1971, 251, 363–369
- Marks WH, Eddeland A, Ohlsson K. Hoppe-Seylers Z Physiol Chem 1981, 363, 1653–1656
- Trautschold I, Werle E, Fritz H. Neue Aspekte der Trasylol Therapie. Gross and Kroneberg, Stuttgart, 1965
- Stroker W, Waldman TA. Nephron 1974, 13, 35–66